An attracting strategy to maintain immune tolerance toward self-antigens during atherosclerosis could be represented by the modulation of inhibitory pathways, including PD-1/PD-L1 and CTLA-4 receptors (149, 150). This evidence concerns the gene CD274 and atherosclerosis.